Literature DB >> 10497874

Basic fibroblast growth factor stimulates cytosolic phospholipase A2, phospholipase C-gamma1 and phospholipase D through distinguishable signaling mechanisms.

G Sa1, T Das.   

Abstract

Fibroblast growth factors (FGFs) stimulate proliferation, differentiation and motility of different cell types. The cellular effects of FGF are transduced by its interaction with any one of four members of a family of high affinity, cell surface FGF receptors (FGFRs) that have autophosphorylating tyrosine kinase activity. Activation of FGFR causes release of various low molecular weight signaling molecules which are required for the pleotropic effects of FGFs. We report here that basic FGF plays critical role in membrane phospholipid hydrolysis in NIH 3T3 cells that are stably transfected with FGFR1. Upon binding to FGFR1, basic FGF stimulates cytosolic form of phospholipase A2 (cPLA2), phospholipase C-gamma1 (PLC-gamma1) and phospholipase D (PLD), the key enzymes for the production of various lipid second messengers, in a tyrosine kinase-dependent manner. In addition to tyrosine phosphorylation, cPLA2 catalytic activation requires serine phosphorylation by p42 mitogen-activated protein (MAP) kinase and possibly pertussis toxin-sensitive G-protein coupling. On the other hand, phosphatidyl inositol 4,5 bisphosphate (PIP2) hydrolysis requires direct phosphorylation at tyrosine residue of the PLC-gamma1 isozyme. The activation of PLD needs direct or indirect receptor tyrosine kinase and protein kinase C (PKC) activities. Additionally, it also requires botulinum toxin C-sensitive Rho-like G-protein activation. All these results suggest that the pleotropic effects of FGF are exerted through its tyrosine kinase receptors and individual effectors are activated via distinguishable signaling mechanisms according to the cell's need.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10497874     DOI: 10.1023/a:1006970710298

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  54 in total

Review 1.  The interferon system. A bird's eye view of its biochemistry.

Authors:  G C Sen; P Lengyel
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

2.  Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase.

Authors:  A E Koromilas; S Roy; G N Barber; M G Katze; N Sonenberg
Journal:  Science       Date:  1992-09-18       Impact factor: 47.728

3.  Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor.

Authors:  M Einat; D Resnitzky; A Kimchi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  PKR: a new name and new roles.

Authors:  C G Proud
Journal:  Trends Biochem Sci       Date:  1995-06       Impact factor: 13.807

6.  Double-stranded RNA-dependent eIF-2alpha protein kinase.

Authors:  R Petryshyn; D H Levin; I M London
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2.

Authors:  A G Rowlands; R Panniers; E C Henshaw
Journal:  J Biol Chem       Date:  1988-04-25       Impact factor: 5.157

8.  Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2.

Authors:  H Harada; M Kitagawa; N Tanaka; H Yamamoto; K Harada; M Ishihara; T Taniguchi
Journal:  Science       Date:  1993-02-12       Impact factor: 47.728

9.  The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2.

Authors:  M V Davies; O Elroy-Stein; R Jagus; B Moss; R J Kaufman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

10.  Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase.

Authors:  Y L Yang; L F Reis; J Pavlovic; A Aguzzi; R Schäfer; A Kumar; B R Williams; M Aguet; C Weissmann
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  7 in total

Review 1.  Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.

Authors:  David A Foster
Journal:  Biochim Biophys Acta       Date:  2009-03-02

2.  Interaction of connexin43 and protein kinase C-delta during FGF2 signaling.

Authors:  Corinne Niger; Carla Hebert; Joseph P Stains
Journal:  BMC Biochem       Date:  2010-03-25       Impact factor: 4.059

3.  PLD2 has both enzymatic and cell proliferation-inducing capabilities, that are differentially regulated by phosphorylation and dephosphorylation.

Authors:  Karen M Henkels; Stephen Short; Hong-Juan Peng; Mauricio Di Fulvio; Julian Gomez-Cambronero
Journal:  Biochem Biophys Res Commun       Date:  2009-08-26       Impact factor: 3.575

Review 4.  The mechanical activation of mTOR signaling: an emerging role for late endosome/lysosomal targeting.

Authors:  Brittany L Jacobs; Craig A Goodman; Troy A Hornberger
Journal:  J Muscle Res Cell Motil       Date:  2013-10-29       Impact factor: 2.698

5.  Connexin43 potentiates osteoblast responsiveness to fibroblast growth factor 2 via a protein kinase C-delta/Runx2-dependent mechanism.

Authors:  Florence Lima; Corinne Niger; Carla Hebert; Joseph P Stains
Journal:  Mol Biol Cell       Date:  2009-04-01       Impact factor: 4.138

Review 6.  New concepts in phospholipase D signaling in inflammation and cancer.

Authors:  Julian Gomez-Cambronero
Journal:  ScientificWorldJournal       Date:  2010-07-07

7.  Modulatory role of phospholipase D in the activation of signal transducer and activator of transcription (STAT)-3 by thyroid oncogenic kinase RET/PTC.

Authors:  Young-Rae Kim; Hee Sun Byun; Minho Won; Kyeong Ah Park; Jin Man Kim; Byung Lyul Choi; Hyunji Lee; Jang Hee Hong; Jongsun Park; Jeong Ho Seok; Dong Wook Kim; Minho Shong; Seung-Kiel Park; Gang Min Hur
Journal:  BMC Cancer       Date:  2008-05-23       Impact factor: 4.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.